YPYoonseo Park

Yoonseo Park

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yoonseo Park has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Bada Jeong

    Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea

    1 shared publication
  • Camilla Giovino

    Department of Medical Biophysics, University of Toronto; Toronto, Ontario, Canada

    1 shared publication
  • Chanju Jung

    Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea

    1 shared publication
  • David Malkin

    Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada

    1 shared publication
  • Doyoon Kim

    Department of MetaBioHealth, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea

    1 shared publication
  • Heesoo Uhm

    Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea

    1 shared publication

Latest Publications

  • Open Access

    A microbiota-dependent gut bile acid axis links germline mutant p53 to distal tumour growth

    by Noel Wei Yang Ong, Nicholas William Fischer, Camilla Giovino, Paula Rosanna Quaglietta, Yoonseo Park, Raya Traubici, David Malkin

    The gut microbiome can influence cancer development, but its contribution to cancer predisposition in Li-Fraumeni Syndrome (LFS) remains poorly understood. Here, we investigated whether germline mutant p53 alters the intestinal environment using Trp53 R172H/+ mice. Tumour-naïve mutant mice exhibited increased intestinal permeability and a pro-inflammatory colonic phenotype, including elevated inflammatory cytokines and enhanced NF-κB signalling. Untargeted metabolomic profiling revealed a striking alteration in bile acid metabolism, with targeted analysis identifying increases in multiple primary and microbiota-derived secondary bile acids. Notably, these changes occurred despite no detectable differences in overall microbial community composition, suggesting altered host–microbial metabolic output in the absence of broad compositional change. Several faecal bile acids were positively associated with distal tumour burden, with the microbiota-derived secondary bile acid deoxycholic acid (DCA) showing the strongest relationship. Microbiota depletion reduced distal tumour growth in mutant mice and attenuated intestinal barrier dysfunction, colonic inflammation and the altered faecal bile acid profile, including DCA. Conversely, transfer of cell-free faecal filtrate from mutant donors to WT recipients induced colonic inflammation and enhanced distal tumour growth. Together, these findings identify a mutant p53–gut axis in which germline mutant p53 establishes a microbiota-shaped metabolic and inflammatory intestinal environment capable of promoting tumour growth beyond the gut.

  • Open Access

    Precise genomic integration of large DNA fragments by donor-directed annealing using prime editing

    by Hojun Jung, Bada Jeong, Yong-Woo Kim, Chanju Jung, Seoho Lee, Heesoo Uhm, Hyoungrak Kim, Ye Eun Oh, Yoonseo Park, Yeji Lee, et al.